BIODESIX INC·4

Mar 14, 5:56 PM ET

Georgantas Robert William III 4

4 · BIODESIX INC · Filed Mar 14, 2022

Insider Transaction Report

Form 4
Period: 2022-03-10
Georgantas Robert William III
DirectorSVP, Rsrch & Trans'l Science
Transactions
  • Award

    Stock Options (Right to buy)

    2022-03-10+22,72222,722 total
    Exercise: $2.29From: 2022-03-10Exp: 2032-03-09Common Stock (22,722 underlying)

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4